QcrB inhibition as a potential approach for the treatment of tuberculosis: A review of recent developments, patents, and future directions

QcrB inhibition as a potential approach for the treatment of tuberculosis: A review of recent developments, patents, and future directions

The unmet medical need for drug-resistant tuberculosis (DRTB) is a significant concern. Accordingly, identifying new drug targets for tuberculosis (TB) treatment and developing new therapies based on these drug targets is one of the strategies to tackle DRTB. QcrB is an innovative drug target to cre...

Full description

Bibliographic Details
Main Authors: Mohd. Imran, Abida, Nawaf M. Alotaibi, Hamdy K. Thabet, Jamal A. Alruwaili, Syed M.B. Asdaq, Lina Eltaib, Ahmed Alshehri, Ahad A. Alsaiari, Mazen Almehmadi, Amal B. Hommod Alshammari, Abdulmajeed M. Alshammari
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Journal of Infection and Public Health
Subjects:
Tuberculosis
Treatment
QcrB inhibitors
Telacebec
Patent
Online Access:http://www.sciencedirect.com/science/article/pii/S1876034123001314

Internet

http://www.sciencedirect.com/science/article/pii/S1876034123001314

Similar Items